GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (OTCPK:CLVSF) » Definitions » Gross Profit

CellaVision AB (CellaVision AB) Gross Profit : $45.10 Mil (TTM As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is CellaVision AB Gross Profit?

CellaVision AB's gross profit for the three months ended in Mar. 2024 was $10.76 Mil. CellaVision AB's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was $45.10 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. CellaVision AB's gross profit for the three months ended in Mar. 2024 was $10.76 Mil. CellaVision AB's Revenue for the three months ended in Mar. 2024 was $16.34 Mil. Therefore, CellaVision AB's Gross Margin % for the quarter that ended in Mar. 2024 was 65.89%.

CellaVision AB had a gross margin of 65.89% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of CellaVision AB was 74.25%. The lowest was 66.40%. And the median was 70.33%.

Warning Sign:

CellaVision AB gross margin has been in long-term decline. The average rate of decline per year is -1.6%.


CellaVision AB Gross Profit Historical Data

The historical data trend for CellaVision AB's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellaVision AB Gross Profit Chart

CellaVision AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.70 37.43 43.16 42.24 45.14

CellaVision AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.25 11.04 10.05 13.25 10.76

Competitive Comparison of CellaVision AB's Gross Profit

For the Medical Devices subindustry, CellaVision AB's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellaVision AB's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's Gross Profit distribution charts can be found below:

* The bar in red indicates where CellaVision AB's Gross Profit falls into.



CellaVision AB Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

CellaVision AB's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=66.028 - 20.887
=45.14

CellaVision AB's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=16.336 - 5.572
=10.76

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $45.10 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

CellaVision AB's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=10.76 / 16.336
=65.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


CellaVision AB  (OTCPK:CLVSF) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

CellaVision AB had a gross margin of 65.89% for the quarter that ended in Mar. 2024 => Durable competitive advantage


CellaVision AB Gross Profit Related Terms

Thank you for viewing the detailed overview of CellaVision AB's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


CellaVision AB (CellaVision AB) Business Description

Traded in Other Exchanges
Address
Mobilvagen 12, Lund, SWE, 22362
CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers.

CellaVision AB (CellaVision AB) Headlines

From GuruFocus

3 Scandinavian Companies With Strong Margin Growth

By James Li James Li 12-01-2020